Your browser doesn't support javascript.
loading
Response to: 'Is it time to redefine the role of low-dose radiotherapy for benign disease?' by Montero et al.
Mahler, Elien A M; Minten, Michiel Jm; Leseman-Hoogenboom, Mathilde M; Poortmans, Philip M P; Leer, Jan Willem; Boks, Simone S; van den Hoogen, Frank H J; den Broeder, Alfons A; van den Ende, Cornelia H.
Afiliação
  • Mahler EAM; Department of Rheumatology, Sint Maartenskliniek Nijmegen, Nijmegen, The Netherlands e.mahler@maartenskliniek.nl.
  • Minten MJ; Department of Rheumatology, Sint Maartenskliniek Nijmegen, Nijmegen, The Netherlands.
  • Leseman-Hoogenboom MM; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Poortmans PMP; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Leer JW; Department of Radiation Oncology, Institut Curie, Paris, France.
  • Boks SS; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van den Hoogen FHJ; Department of Radiology, Sint Maartenskliniek Nijmegen, Nijmegen, The Netherlands.
  • den Broeder AA; Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van den Ende CH; Department of Rheumatology, Sint Maartenskliniek Nijmegen, Nijmegen, The Netherlands.
Ann Rheum Dis ; 79(3): e35, 2020 03.
Article em En | MEDLINE | ID: mdl-30709815

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteoartrite do Joelho Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteoartrite do Joelho Idioma: En Ano de publicação: 2020 Tipo de documento: Article